Ipca Laboratories Results Earnings Call for Q1FY24

Conference Call with Ipca Laboratories Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.
11-08-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Re-Appointment Of Mr. Pranay Godha As Managing Director

Re-appointment of Mr. Pranay Godha as Managing Director
10-08-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Proceedings of the 73rd Annual General Meeting held on 10th August, 2023
10-08-2023
Bigul

Q1FY24 Quarterly Result Announced for Ipca Laboratories Ltd.

Pharmaceuticals company Ipca Laboratories announced Q1FY24 results: Consolidated Q1FY24: Net Total Income of Rs 1,632.43 crore in Q1FY24 as against Rs 1,607.85 crore in Q1FY23. EBIDTA margin (before forex (gain)/loss and other income) of 18.53% in Q1FY24 as against 17.88% in Q1FY23. Net Profit up 14% at Rs 162.82 crore. Standalone Q1FY24: Net Total Income of Rs 1,531.87 crore in Q1FY24 as against Rs 1,496.24 crore in Q1FY23. Exports Income of Rs 615.26 crore in Q1FY24 as against Rs 689.41 crore in Q1FY23. EBIDTA margin (before forex (gain)/loss and other income) of 19.08% in Q1FY24 as against 18.21% in Q1FY23. Net Profit up 19% at Rs 166.58 crore. Result PDF
10-08-2023

IPCA Labs Q1 results: Net profit rises 14% to Rs 163 crore

IPCA Labs Q1 earnings: The pharma company had reported a net profit of Rs 143.06 crore in the year-ago period
10-08-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Standalone And Consolidated Q1FY24 Results & Press Release

Standalone and Consolidated Q1FY24 Results & Press Release
10-08-2023
Next Page
Close

Let's Open Free Demat Account